BIONTECH

biontech-logo

BioNTech is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.

#SimilarOrganizations #People #Financial #Website #More

BIONTECH

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2008-01-01

Address:
Mainz, Rheinland-Pfalz, Germany

Country:
Germany

Website Url:
http://www.biontech.de

Total Employee:
1001+

Status:
Active

Contact:
+49 6131 90-840

Email Addresses:
[email protected]

Total Funding:
1.74 B USD

Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Amazon Organization Schema IPv6 ReCAPTCHA JsDelivr Cloudflare JS US Privacy User Signal Mechanism


Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.


Current Advisors List

christoph-huber_image

Christoph Huber Member of the Supervisory Board @ BioNTech
Board_member

Current Employees Featured

ugur-sahin_image

Ugur Sahin
Ugur Sahin Co-Founder and CEO @ BioNTech
Co-Founder and CEO

christoph-huber_image

Christoph Huber
Christoph Huber Cofounder & deputy chair supervisory board @ BioNTech
Cofounder & deputy chair supervisory board
2008-01-01

christoph-krรถner_image

Christoph Krรถner
Christoph Krรถner Director DNA Process Development & Cap Technology @ BioNTech
Director DNA Process Development & Cap Technology

jesse-dong_image

Jesse Dong
Jesse Dong Vice President, Peptide Chemistry @ BioNTech
Vice President, Peptide Chemistry
2020-05-01

andreas-kuhn_image

Andreas Kuhn
Andreas Kuhn Senior Vice President RNA Biochemistry & Manufacturing @ BioNTech
Senior Vice President RNA Biochemistry & Manufacturing
2019-01-01

michael-boehler_image

Michael Boehler
Michael Boehler Vice President Global Commercial and General Manager @ BioNTech
Vice President Global Commercial and General Manager
2020-08-01

arvind-m-hundal-phd_image

Arvind m. Hundal Ph.d.
Arvind m. Hundal Ph.d. SVP Business Development @ BioNTech
SVP Business Development
2019-05-01

marc-wolfgang_image

Marc Wolfgang
Marc Wolfgang VP Technical Operations @ BioNTech
VP Technical Operations
2020-05-01

Founder


christoph-huber_image

Christoph Huber

ugur-sahin_image

Ugur Sahin

Stock Details


Company's stock symbol is NASDAQ:BNTX

Acquisitions List

Date Company Article Price
2021-11-09 PhagoMed PhagoMed acquired by BioNTech N/A
2021-07-19 Kite - TCR therapy Kite - TCR therapy acquired by BioNTech N/A
2020-01-16 Neon Therapeutics Neon Therapeutics acquired by BioNTech 67 M USD

Investors List

german-federal-ministry-of-education-and-research-bmbf_image

German Federal Ministry of Education and Research (BMBF)

German Federal Ministry of Education and Research (BMBF) investment in Grant - BioNTech

temasek_image

Temasek Holdings

Temasek Holdings investment in Post-IPO Equity - BioNTech

european-investment-bank_image

European Investment Bank

European Investment Bank investment in Post-IPO Debt - BioNTech

european-investment-bank_image

European Investment Bank

European Investment Bank investment in Post-IPO Debt - BioNTech

bill-melinda-gates-foundation_image

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation investment in Venture Round - BioNTech

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series B - BioNTech

platinum-asset-management_image

Platinum Asset Management

Platinum Asset Management investment in Series B - BioNTech

miraeasset-financial-group_image

MiraeAsset Financial Group

MiraeAsset Financial Group investment in Series B - BioNTech

jebsen-capital_image

Jebsen Capital

Jebsen Capital investment in Series B - BioNTech

invus_image

Invus

Invus investment in Series B - BioNTech

Investments List

Date Company Article Money raised
2022-02-02 MediGene BioNTech investment in Post-IPO Equity - MediGene 26 M EUR
2022-01-25 InstaDeep BioNTech investment in Series B - InstaDeep 100 M USD

Official Site Inspections

http://www.biontech.de Semrush global rank: 291.45 K Semrush visits lastest month: 228.31 K

  • Host name: a23-73-207-14.deploy.static.akamaitechnologies.com
  • IP address: 23.73.207.14
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BioNTech" on Search Engine